{"id":7128,"date":"2023-07-13T00:13:40","date_gmt":"2023-07-13T00:13:40","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=7128"},"modified":"2023-08-29T17:58:36","modified_gmt":"2023-08-29T17:58:36","slug":"incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=7128","title":{"rendered":"Incannex Healthcare\u83b7\u5f97HREC\u6279\u51c6\uff0c\u7528\u4e8e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u7684IHL-675A II\u671f\u4e34\u5e8a\u8bd5\u9a8c"},"content":{"rendered":"

\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u516c\u53f8 Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97 Bellberry \u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a (HREC) \u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u7ef4\u591a\u5229\u4e9a Emeritus Research \u573a\u6240\u5f00\u5c55\u5019\u9009\u836f\u7269 IHL-675A \u7684 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n

\u8be5\u5173\u952e\u8bd5\u9a8c\u5c06\u8bc4\u4f30 IHL-675A \u4f5c\u4e3a\u4e13\u6709\u6297\u708e\u7ec4\u5408\u836f\u7269\u7528\u4e8e\u7c7b\u98ce\u6e7f\u5173\u8282\u708e\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002<\/p>\n

\u5b83\u9075\u5faa\u52a8\u7269\u7814\u7a76\u89c2\u5bdf\u7ed3\u679c\uff0cIHL-675A \u6bd4\u786b\u9178\u7f9f\u6c2f\u55b9 (HCQ) \u80fd\u66f4\u5927\u7a0b\u5ea6\u5730\u663e\u7740\u964d\u4f4e\u708e\u75c7\u6027\u75be\u75c5\u8bc4\u5206\uff0c\u540e\u8005\u662f\u4e00\u79cd\u957f\u671f\u5b58\u5728\u7684\u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684\u5e38\u89c1\u5904\u65b9\u836f\uff08\u79f0\u4e3a\u201cPlaquenil\u201d\uff09\uff0c\u5177\u6709\u76f8\u5f53\u5927\u7684\u5e02\u573a\u77e5\u540d\u5ea6\u3002<\/p>\n

Incannex \u5e0c\u671b IHL-675A \u5728\u8fd9\u9879\u5e7f\u6cdb\u7684 2 \u671f\u7597\u6548\u8bd5\u9a8c\u4e2d\u7684\u89c2\u5bdf\u7ed3\u679c\u4e2d\u7ee7\u7eed\u4f18\u4e8e Plaquenil\u3002<\/p>\n

\u8be5\u8bd5\u9a8c\u5c06\u5229\u7528 24 \u5468\u5185\u60a3\u8005\u62a5\u544a\u7684\u7ed3\u679c\u3001\u75be\u75c5\u8bc4\u5206\u548c\u708e\u75c7\u751f\u7269\u6807\u5fd7\u7269\u5206\u6790\u6765\u8bc4\u4f30 IHL-675A \u5bf9\u75bc\u75db\u548c\u529f\u80fd\u7684\u5f71\u54cd\u3002<\/p>\n

\u5b83\u5c06\u5305\u62ec\u4e00\u9879\u901a\u8fc7 MRI\uff08\u78c1\u5171\u632f\u6210\u50cf\uff09\u68c0\u67e5\u5173\u8282\u635f\u4f24\u7684\u5b50\u7814\u7a76\u3002<\/p>\n

\u5c06\u6839\u636e\u7b5b\u9009\u65f6\u7684\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e MRI \u8bc4\u5206 (RAMRIS) \u8bc4\u4f30\u60a3\u8005\u53c2\u52a0\u5b50\u7814\u7a76\u7684\u8d44\u683c\u3002<\/p>\n

\u8bd5\u7528\u7ba1\u7406<\/h2>\n

\u8be5\u8bd5\u9a8c\u5c06\u7531\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u5408\u540c\u7814\u7a76\u7ec4\u7ec7 Avance Clinical \u7ba1\u7406\uff0c\u8be5\u7ec4\u7ec7\u5c06\u5728\u6fb3\u5927\u5229\u4e9a\u548c\u65b0\u897f\u5170\u7684\u591a\u8fbe 10 \u4e2a\u5730\u70b9\u8fdb\u884c\u8bd5\u9a8c\uff0c\u5e76\u62db\u52df\u603b\u5171 128 \u540d\u5728\u63a5\u53d7\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7a33\u5b9a\u6cbb\u7597\u671f\u95f4\u6301\u7eed\u75bc\u75db\u548c\u529f\u80fd\u51cf\u9000\u7684\u60a3\u8005\u3002<\/p>\n

\u60a3\u8005\u5c06\u88ab\u968f\u673a\u5206\u914d\u5230 IHL-675A\u3001\u5355\u72ec CBD\u3001\u5355\u72ec HCQ \u6216\u5b89\u6170\u5242\u7ec4\uff0c\u4e3b\u8981\u7ec8\u70b9\u662f\u76f8\u5bf9\u4e8e\u57fa\u7ebf\u7684\u75bc\u75db\u548c\u529f\u80fd\uff0c\u901a\u8fc7 24 \u5468\u65f6\u884c\u4e1a\u6807\u51c6 RAPID3 \u8bc4\u4f30\u7684\u5206\u6570\u786e\u5b9a\u3002<\/p>\n

\u4ed6\u4eec\u5c06\u4f7f\u7528\u7535\u5b50\u8bbe\u5907\u901a\u8fc7\u75b2\u52b3\u3001\u5173\u8282\u50f5\u786c\u548c\u751f\u6d3b\u8d28\u91cf\u7684\u8c03\u67e5\u95ee\u5377\u8bb0\u5f55\u6bcf\u5929\u7684\u75bc\u75db\u548c\u529f\u80fd\u7ed3\u679c\u3002<\/p>\n

\u7ed3\u679c\u5c06\u786e\u5b9a IHL-675A \u5728\u7c7b\u98ce\u6e7f\u5173\u8282\u708e\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u5e76\u6709\u52a9\u4e8e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40 505(b)2 \u65b0\u836f\u7533\u8bf7\u6863\u6848\u4e2d\u7684\u7ec4\u5408\u89c4\u5219\u8bc4\u4f30\u3002<\/p>\n

\u6b22\u8fce\u6279\u51c6<\/h2>\n

Incannex \u9996\u5e2d\u79d1\u5b66\u5b98 Mark Blackley \u535a\u58eb\u5bf9 HREC \u7684\u6279\u51c6\u8868\u793a\u6b22\u8fce\u3002<\/p>\n

\u4ed6\u8bf4\uff1a\u201cHREC \u5bf9\u6211\u4eec 2 \u671f\u8bd5\u9a8c\u7684\u6279\u51c6\u662f\u5f00\u53d1 IHL-675A \u7684\u5173\u952e\u4e00\u6b65\uff0c\u8be5 IHL-675A \u7528\u4e8e\u6cbb\u7597\u4e0e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u76f8\u5173\u7684\u75bc\u75db\u548c\u529f\u80fd\u4e0b\u964d\u3002\u201d<\/p>\n

\u201c\u6211\u4eec\u671f\u5f85\u4e0e Emeritus \u548c Avance \u5408\u4f5c\uff0c\u8bc4\u4f30[\u8be5\u836f\u7269]\u5bf9\u8be5\u60a3\u8005\u7fa4\u4f53\u7684\u6548\u679c\u3002\u201d<\/p>\n

\u7b2c\u4e00\u9636\u6bb5\u7814\u7a76<\/h2>\n

\u7b2c\u4e8c\u9636\u6bb5\u8bd5\u9a8c\u662f\u5728\u7b2c\u4e00\u9636\u6bb5\u7814\u7a76\u6210\u529f\u4e4b\u540e\u8fdb\u884c\u7684\uff0c\u5176\u4e2d\u6d3b\u6027\u836f\u7269\u6210\u5206\u5927\u9ebb\u4e8c\u915a (CBD) \u548c HCQ \u4ece\u56fa\u5b9a\u5242\u91cf\u7ec4\u5408 IHL-675A \u4e2d\u88ab\u5438\u6536\u3002<\/p>\n

\u636e\u89c2\u5bdf\uff0c\u8be5\u836f\u7269\u8010\u53d7\u6027\u826f\u597d\uff0c\u6ca1\u6709\u4e0d\u826f\u4e8b\u4ef6\u53d1\u751f\u3002<\/p>\n

\u5728\u5f00\u59cb\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u524d\uff0cIncannex \u89c2\u5bdf\u5230\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u52a8\u7269\u6a21\u578b\u7684\u79ef\u6781\u7ed3\u679c\uff0c\u8868\u660e\u8be5\u836f\u7269\u5728\u591a\u9879\u8bc4\u4f30\uff08\u5305\u62ec\u4e34\u5e8a\u8bc4\u5206\u3001\u722a\u5b50\u4f53\u79ef\u3001\u8840\u7ba1\u7ff3\u8bc4\u5206\u3001\u603b\u7ec4\u7ec7\u5b66\u8bc4\u5206\u548c\u8840\u6e05\u7ec6\u80de\u56e0\u5b50\u6c34\u5e73\uff09\u65b9\u9762\u66f4\u6709\u6548\u5730\u51cf\u5c11\u5173\u8282\u708e\u3002 \u6bd4\u556e\u9f7f\u52a8\u7269\u7b49\u6548\u7684 HCQ \u6807\u51c6\u5242\u91cf\u6216 CBD \u7684\u7b49\u6548\u5242\u91cf\u3002<\/p>\n

\u201cIHL-675A \u6240\u5b9e\u73b0\u7684\u75be\u75c5\u8bc4\u4f30\u51cf\u5c11\u91cf\u662f\u6807\u51c6\u5242\u91cf\u4e0b\u5355\u72ec\u4f7f\u7528 HCQ \u7684 3.52 \u500d\uff0c\u201dBlackley \u535a\u58eb\u8bf4\u3002<\/p>\n

\u201c\u8fd9\u4e9b\u6709\u5e0c\u671b\u7684\u89c2\u5bdf\u7ed3\u679c\u4f7f\u6211\u4eec\u4f18\u5148\u8003\u8651\u5feb\u901f\u4e34\u5e8a\u8bc4\u4f30\uff0c\u7279\u522b\u662f\u8003\u8651\u5230 HCQ\uff08Plaquenil \u54c1\u724c\uff09\u662f\u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684\u5e38\u7528\u7597\u6cd5\u3002\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u516c\u53f8 Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97 Bellberry \u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a (HREC) \u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u7ef4\u591a\u5229\u4e9a Emeritus Research \u573a\u6240\u5f00\u5c55\u5019\u9009\u836f\u7269 IHL-675A \u7684 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u8be5\u5173\u952e\u8bd5\u9a8c\u5c06\u8bc4\u4f30 IHL-675A \u4f5c\u4e3a\u4e13\u6709\u6297\u708e\u7ec4\u5408\u836f\u7269\u7528\u4e8e\u7c7b\u98ce\u6e7f\u5173\u8282\u708e\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002 \u5b83\u9075\u5faa\u52a8\u7269\u7814\u7a76\u89c2\u5bdf\u7ed3\u679c\uff0cIHL-675A \u6bd4\u786b\u9178\u7f9f\u6c2f\u55b9 (HCQ) \u80fd\u66f4\u5927\u7a0b\u5ea6\u5730\u663e\u7740\u964d\u4f4e\u708e\u75c7\u6027\u75be\u75c5\u8bc4\u5206\uff0c\u540e\u8005\u662f\u4e00\u79cd\u957f\u671f\u5b58\u5728\u7684\u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684\u5e38\u89c1\u5904\u65b9\u836f\uff08\u79f0\u4e3a\u201cPlaquenil\u201d\uff09\uff0c\u5177\u6709\u76f8\u5f53\u5927\u7684\u5e02\u573a\u77e5\u540d\u5ea6\u3002 Incannex \u5e0c\u671b IHL-675A \u5728\u8fd9\u9879\u5e7f\u6cdb\u7684 2 \u671f\u7597\u6548\u8bd5\u9a8c\u4e2d\u7684\u89c2\u5bdf\u7ed3\u679c\u4e2d\u7ee7\u7eed\u4f18\u4e8e Plaquenil\u3002 \u8be5\u8bd5\u9a8c\u5c06\u5229\u7528 24 \u5468\u5185\u60a3\u8005\u62a5\u544a\u7684\u7ed3\u679c\u3001\u75be\u75c5\u8bc4\u5206\u548c\u708e\u75c7\u751f\u7269\u6807\u5fd7\u7269\u5206\u6790\u6765\u8bc4\u4f30 IHL-675A \u5bf9\u75bc\u75db\u548c\u529f\u80fd\u7684\u5f71\u54cd\u3002 \u5b83\u5c06\u5305\u62ec\u4e00\u9879\u901a\u8fc7 MRI\uff08\u78c1\u5171\u632f\u6210\u50cf\uff09\u68c0\u67e5\u5173\u8282\u635f\u4f24\u7684\u5b50\u7814\u7a76\u3002 \u5c06\u6839\u636e\u7b5b\u9009\u65f6\u7684\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e MRI \u8bc4\u5206 (RAMRIS) \u8bc4\u4f30\u60a3\u8005\u53c2\u52a0\u5b50\u7814\u7a76\u7684\u8d44\u683c\u3002 \u8bd5\u7528\u7ba1\u7406 \u8be5\u8bd5\u9a8c\u5c06\u7531\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u5408\u540c\u7814\u7a76\u7ec4\u7ec7 Avance Clinical \u7ba1\u7406\uff0c\u8be5\u7ec4\u7ec7\u5c06\u5728\u6fb3\u5927\u5229\u4e9a\u548c\u65b0\u897f\u5170\u7684\u591a\u8fbe 10 \u4e2a\u5730\u70b9\u8fdb\u884c\u8bd5\u9a8c\uff0c\u5e76\u62db\u52df\u603b\u5171 128 \u540d\u5728\u63a5\u53d7\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7a33\u5b9a\u6cbb\u7597\u671f\u95f4\u6301\u7eed\u75bc\u75db\u548c\u529f\u80fd\u51cf\u9000\u7684\u60a3\u8005\u3002 \u60a3\u8005\u5c06\u88ab\u968f\u673a\u5206\u914d\u5230 IHL-675A\u3001\u5355\u72ec CBD\u3001\u5355\u72ec… Continue reading Incannex Healthcare\u83b7\u5f97HREC\u6279\u51c6\uff0c\u7528\u4e8e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u7684IHL-675A II\u671f\u4e34\u5e8a\u8bd5\u9a8c<\/span><\/a><\/p>\n","protected":false},"author":4,"featured_media":18782,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[33],"yoast_head":"\nIncannex Healthcare\u83b7\u5f97HREC\u6279\u51c6\uff0c\u7528\u4e8e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u7684IHL-675A II\u671f\u4e34\u5e8a\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u516c\u53f8 Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97 Bellberry \u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a (HREC) \u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u7ef4\u591a\u5229\u4e9a Emeritus Research \u573a\u6240\u5f00\u5c55\u5019\u9009\u836f\u7269 IHL-675A \u7684 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incannex Healthcare\u83b7\u5f97HREC\u6279\u51c6\uff0c\u7528\u4e8e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u7684IHL-675A II\u671f\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u516c\u53f8 Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97 Bellberry \u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a (HREC) \u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u7ef4\u591a\u5229\u4e9a Emeritus Research \u573a\u6240\u5f00\u5c55\u5019\u9009\u836f\u7269 IHL-675A \u7684 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-13T00:13:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:58:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Incannex-Healthcare-ASX-IHL-IHL-675A-Phase-2-trial-patients-rheumatoid-arthritis-HREC-approval.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/\",\"name\":\"Incannex Healthcare\u83b7\u5f97HREC\u6279\u51c6\uff0c\u7528\u4e8e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u7684IHL-675A II\u671f\u4e34\u5e8a\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-07-13T00:13:40+00:00\",\"dateModified\":\"2023-08-29T17:58:36+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u516c\u53f8 Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97 Bellberry \u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a (HREC) \u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u7ef4\u591a\u5229\u4e9a Emeritus Research \u573a\u6240\u5f00\u5c55\u5019\u9009\u836f\u7269 IHL-675A \u7684 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Incannex Healthcare\u83b7\u5f97HREC\u6279\u51c6\uff0c\u7528\u4e8e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u7684IHL-675A II\u671f\u4e34\u5e8a\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Incannex Healthcare\u83b7\u5f97HREC\u6279\u51c6\uff0c\u7528\u4e8e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u7684IHL-675A II\u671f\u4e34\u5e8a\u8bd5\u9a8c","description":"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u516c\u53f8 Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97 Bellberry \u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a (HREC) \u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u7ef4\u591a\u5229\u4e9a Emeritus Research \u573a\u6240\u5f00\u5c55\u5019\u9009\u836f\u7269 IHL-675A \u7684 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Incannex Healthcare\u83b7\u5f97HREC\u6279\u51c6\uff0c\u7528\u4e8e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u7684IHL-675A II\u671f\u4e34\u5e8a\u8bd5\u9a8c","og_description":"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u516c\u53f8 Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97 Bellberry \u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a (HREC) \u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u7ef4\u591a\u5229\u4e9a Emeritus Research \u573a\u6240\u5f00\u5c55\u5019\u9009\u836f\u7269 IHL-675A \u7684 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/","og_site_name":"smallcapsCN","article_published_time":"2023-07-13T00:13:40+00:00","article_modified_time":"2023-08-29T17:58:36+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Incannex-Healthcare-ASX-IHL-IHL-675A-Phase-2-trial-patients-rheumatoid-arthritis-HREC-approval.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/","url":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/","name":"Incannex Healthcare\u83b7\u5f97HREC\u6279\u51c6\uff0c\u7528\u4e8e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u7684IHL-675A II\u671f\u4e34\u5e8a\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-07-13T00:13:40+00:00","dateModified":"2023-08-29T17:58:36+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u516c\u53f8 Incannex Healthcare (ASX: IHL) \u5df2\u83b7\u5f97 Bellberry \u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a (HREC) \u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u7ef4\u591a\u5229\u4e9a Emeritus Research \u573a\u6240\u5f00\u5c55\u5019\u9009\u836f\u7269 IHL-675A \u7684 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-receives-hrec-approval-ihl-675a-phase-2-trial-patients-rheumatoid-arthritis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Incannex Healthcare\u83b7\u5f97HREC\u6279\u51c6\uff0c\u7528\u4e8e\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u7684IHL-675A II\u671f\u4e34\u5e8a\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/7128"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7128"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/7128\/revisions"}],"predecessor-version":[{"id":20926,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/7128\/revisions\/20926"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18782"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7128"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7128"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}